Sommetrics

Sommetrics is a clinical-stage medical device company targeting the massive, underserved global sleep apnea market. The company's lead platform, aer+ technology, represents a novel, non-invasive approach to treating airway narrowing by applying negative external pressure (vacuum) via a soft collar worn around the neck. This mechanism of action is fundamentally different from positive pressure (CPAP) or implantable devices, potentially offering a more comfortable and compliant solution. Sommetrics is advancing its lead product through a pivotal clinical trial (SUPRA study) and has an FDA-cleared acute care product, aerFree, being commercialized by a separate entity.

Proprietary aer+ technology involving the application of negative external pressure (vacuum) to the outside of the neck via a soft collar to stabilize the upper airway and prevent collapse during sleep.

Sommetrics competes in the crowded sleep apnea treatment market, dominated by CPAP devices (ResMed, Philips) and supplemented by oral appliances, hypoglossal nerve stimulators (Inspire Medical), and surgical options. Its primary competitive angle is its novel external negative pressure mechanism, which aims to offer efficacy similar to CPAP with a potentially more user-friendly form factor to drive better compliance, a major weakness of the current market leader.